Article

Geisinger Scientists Lead Multinational Study of COVID-19 and Stroke

Data shows low correlation between coronavirus disease (COVID) infection and stroke.

DANVILLE, Pa. – Geisinger scientists led a team of experts from around the world to study the correlation between coronavirus disease 2019 (COVID-1)9 infection and stroke risk.

The multinational COVID-19 Stroke Study Group included scientists and clinicians from 99 medical centers in 11 countries. The team was led by Ramin Zand, MD, a vascular neurologist and clinician-scientist at Geisinger, and coordinated by Shima Shahjouei, MD, a postdoctoral stroke fellow at Geisinger.

Some reported symptoms and effects of COVID-19 involve the nervous system, ranging from a loss of smell or taste to more severe and life-threatening conditions such as altered mental state, meningitis, and stroke. The first phase of the study, which included data on 26,175 patients, indicated an overall stroke risk of 0.5% to 1.2% among hospitalized patients with COVID-19 infection. The finding demonstrated that, even though there are increasing reports of patients with COVID-19 experiencing stroke, the overall risk is low.

The study results were published this month in EbioMedicine, a publication of The Lancet.

Learn more.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Mansi Shah, MD
Dr Ibrahim Aldoss
Mansi Shah, MD
Dr John Mascarenhas
Merrill H. Stewart, MD
Dr John Mascarenhas
Dr Sundar Jagannath
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo